Correction to Novartis CEO story
February 19 2018 - 6:31AM
Dow Jones News
Dr. Narasimhan, a U.S. citizen of Indian descent, joined
Novartis in 2005 from consultancy McKinsey & Co., and rose
quickly through the Swiss drugmaker's ranks to become chief medical
officer and global head of drug development. "Novartis CEO Steers
Drug Maker Back to R&D," at 09:02 GMT, incorrectly said Dr.
Narasimhan is a U.S. citizen of Indian descent. A previous version
of this story incorrectly said he was born in India. Dr. Narasimhan
was Novartis' chief medical officer and global head of drug
development. The earlier version of the story incorrectly said he
was head of the company's research and development.
(END) Dow Jones Newswires
February 19, 2018 07:16 ET (12:16 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2024 to May 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From May 2023 to May 2024